A Bug-Fighting Virus Just Got a Major Backer

BASF acquires Texas biocontrol firm AgBiTech to bolster its biological crop protection portfolio

15 Jan 2026

BASF Agricultural Solutions has agreed to acquire AgBiTech, a Fort Worth, Texas-based biocontrol company, from private equity firm Paine Schwartz Partners, the companies announced in January. The deal transfers full ownership of AgBiTech's product portfolio, intellectual property, manufacturing operations, and research facilities to BASF. Financial terms were not disclosed; the transaction is expected to close in the first half of 2026, pending regulatory approval.

Founded in 2000, AgBiTech built its portfolio around nucleopolyhedrovirus technology, which uses naturally occurring viruses to create bioinsecticides targeting caterpillar pests in corn, soybean, and cotton. The company operates in the United States, Brazil, and Australia, with products deployed across the Americas, Africa, and Asia. According to BASF, the acquisition is intended to provide farmers with differentiated, sustainable insect control options, particularly in Brazil, where demand for biological crop protection has grown substantially.

The deal reflects widening consolidation in the agricultural biologicals sector, where major agrochemical companies have moved aggressively to acquire specialized biocontrol firms as synthetic pesticide resistance intensifies across key growing regions. Paine Schwartz Partners, which manages approximately $6.5 billion in assets with a focus on sustainable food chain investing, had backed AgBiTech through its growth phase. For BASF, the acquisition adds a resistance management tool that analysts note carries no cross-resistance to major synthetic insecticide classes, a commercially significant attribute as resistance pressures complicate conventional programs.

Yet the broader question remains how effectively large chemical companies can integrate niche biological platforms without diluting what makes them commercially distinct. Scaling virus-based bioinsecticides across diverse geographies presents formulation, registration, and supply chain challenges that differ markedly from conventional chemistry. Whether BASF can preserve AgBiTech's technical agility within a large corporate structure will likely determine how much the acquisition advances its BioSolutions portfolio in practice. The outcome could influence how rival agrochemical firms approach their own biologicals strategies in the years ahead.